Ulrich Frank Pape

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. doi request reprint Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Endocr Relat Cancer 15:1083-97. 2008
  2. ncbi request reprint Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center
    Ulrich Frank Pape
    Department of Internal Medicine, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Medical Faculty of the Humboldt University, Berlin, Germany
    Ann N Y Acad Sci 1014:222-33. 2004
  3. doi request reprint Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Chariteé Campus Virchow Clinic, Berlin University of Medicine, Berlin, Germany
    Cancer 113:256-65. 2008
  4. ncbi request reprint Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study
    Siegbert Faiss
    Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Augustenburger Platz 1, D 13353 Berlin, Germany
    J Clin Oncol 21:2689-96. 2003
  5. doi request reprint Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome
    Henning Jann
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Cancer 117:3332-41. 2011
  6. doi request reprint Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 39:72-82. 2012
  7. doi request reprint Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
    Vera Froeling
    Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Ann Nucl Med 26:738-43. 2012
  8. ncbi request reprint From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective
    Bertram Wiedenmann
    Department of Internal Medicine, Division of Hepatology and Gastroenterology, Interdisciplinary Center of Metabolism and Endocrinology, Charite, Campus Virchow Hospital, University Medicine Berlin, Berlin, Germany
    Neuroendocrinology 80:94-8. 2004
  9. doi request reprint Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur Radiol 22:458-67. 2012
  10. doi request reprint Magnetic resonance enteroclysis in patients with Crohn's disease: fat saturated T2-weighted sequences for evaluation of inflammatory activity
    Christian Grieser
    Klinik für Radiologie, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    J Crohns Colitis 6:294-301. 2012

Collaborators

Detail Information

Publications15

  1. doi request reprint Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Endocr Relat Cancer 15:1083-97. 2008
    ....
  2. ncbi request reprint Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center
    Ulrich Frank Pape
    Department of Internal Medicine, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Medical Faculty of the Humboldt University, Berlin, Germany
    Ann N Y Acad Sci 1014:222-33. 2004
    ..7% of successfully resected patients. Palliative medical treatment, either with chemotherapy (i.e., especially for foregut NETs) or biotherapy (especially for midgut NETs), was only moderately effective for both therapeutic regimens...
  3. doi request reprint Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Chariteé Campus Virchow Clinic, Berlin University of Medicine, Berlin, Germany
    Cancer 113:256-65. 2008
    ..In 2006, a new TNM classification system was proposed for the staging and grading of upper GEP NETs...
  4. ncbi request reprint Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study
    Siegbert Faiss
    Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Augustenburger Platz 1, D 13353 Berlin, Germany
    J Clin Oncol 21:2689-96. 2003
    ..Until now, however, no prospective, randomized studies in therapy-naive patients have compared somatostatin analogs or interferon alfa alone with a combination of the two...
  5. doi request reprint Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome
    Henning Jann
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Cancer 117:3332-41. 2011
    ..The purpose of this study was to test the efficacy of a proposal for TNM staging and grading for midgut and hindgut NETs...
  6. doi request reprint Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 39:72-82. 2012
    ..The aim of this study was to compare the costs for the two diagnostic tests and the respective consequential costs...
  7. doi request reprint Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
    Vera Froeling
    Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Ann Nucl Med 26:738-43. 2012
    ..To evaluate the impact of Ga-68 DOTATOC PET/CT on diagnosis and therapeutic management of patients with multiple endocrine neoplasia (MEN)...
  8. ncbi request reprint From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective
    Bertram Wiedenmann
    Department of Internal Medicine, Division of Hepatology and Gastroenterology, Interdisciplinary Center of Metabolism and Endocrinology, Charite, Campus Virchow Hospital, University Medicine Berlin, Berlin, Germany
    Neuroendocrinology 80:94-8. 2004
    ..As well, new therapeutic treatment options translated from current findings in the fields of molecular and tumor biology are discussed...
  9. doi request reprint Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur Radiol 22:458-67. 2012
    ..This study was performed to assess the role of retrospective PET-MRI fusion with Ga-68-DOTA(0)-Phe(1)-Tyr(3)-octreotide (Ga-68-DOTATOC) PET and Gd-EOB-DTPA MRI in the detection of hepatic metastases from neuroendocrine tumours (NET)...
  10. doi request reprint Magnetic resonance enteroclysis in patients with Crohn's disease: fat saturated T2-weighted sequences for evaluation of inflammatory activity
    Christian Grieser
    Klinik für Radiologie, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    J Crohns Colitis 6:294-301. 2012
    ..To evaluate fat saturated (fs) T2-weighted (w) fast relaxation fast spin echo (FRFSE)-sequences compared to the standard protocol with contrast agent for the evaluation of inflammatory activity in patients with Crohn's Disease (CD)...
  11. ncbi request reprint Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT
    Juri Ruf
    Klinik fur Strahlenheilkunde, Charite, Centrum 6 für diagnostische und interventionelle Radiologie und Nuklearmedizin, Charite Universitatsmedizin Berlin, Germany
    Nucl Med Commun 28:782-8. 2007
    ..Somatostatin receptor scintigraphy (SRS) is well-established in neuroendocrine tumour (NET) imaging. This study evaluated the impact of attenuation correction (AC) on SRS SPECT data in patients examined by SPECT-CT...
  12. ncbi request reprint Fatal embolic myocardial infarction after systemic thrombolysis for stroke
    Wassilios Meissner
    Department of Neurology, Charite Campus Virchow Klinikum, Humboldt University Berlin, Berlin, Germany
    Cerebrovasc Dis 22:213-4. 2006
  13. doi request reprint Waitlist characteristics of patients at a single-center intestinal and multivisceral transplant program
    Undine A Gerlach
    Department of General, Visceral, and Transplantation Surgery, Charite Universitaetsmedizin Berlin, Berlin, Germany
    Transpl Int 26:392-401. 2013
    ..MVTX-candidates have a high waitlist mortality for different reasons. However, the current allocation policy for MVTX does not mirror the severity of disease and may therefore contribute to high waitlist mortality...
  14. doi request reprint Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
    Andreas Fischer
    Department of Medicine, Division of Gastroenterology and Hepatology, Humboldt University of Berlin, Berlin, Germany
    Am J Physiol Gastrointest Liver Physiol 304:G970-9. 2013
    ..Barrier protection might therefore constitute a novel mechanism how anti-TNF-α therapy contributes to epithelial restitution and tissue repair in inflammatory bowel diseases...
  15. doi request reprint Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group
    Anja Rinke
    Department of Internal Medicine, Division of Gastroenterology and Endocrinology, Institute of Medical Biometry and Epidemiology, Philipps University, Marburg, Germany
    J Clin Oncol 27:4656-63. 2009
    ..We performed a placebo-controlled, double-blind, phase IIIB study in patients with well-differentiated metastatic midgut NETs. The hypothesis was that octreotide LAR prolongs time to tumor progression and survival...